Cardiol Therapeutics Inc. (CRDL) NASDAQ
1.15
-0.07(-5.74%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.15
-0.07(-5.74%)
Currency In USD
| Market Cap | 113.85M |
| Enterprise Value | 92.56M |
| P/E Ratio | -4.89 |
| PEG Ratio | -0.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.16 |
| Return On Equity | -2.29 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -34.21M |
| Net Income | -33.82M |
| Diluted EPS | -0.39 |
| Total Cash | 27.74M |
| Total Cash/Share | 0.25 |
| Total Debt | 116,707 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.39 |
| Book Value Per Share | 0.22 |
| 52-Week Change | -7.26 |
| 52-Week High | 1.71 |
| 52-Week Low | 0.88 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 1.12 |
| Average Volume | 676,719 |
| Shares Outstanding | 111.87M |
| % Held by Institutions | 27.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |